STRAP — Strategic Partners A/S Share News
0.000.00%
Last trade - 00:00- DKK31.66m
- DKK31.58m
- DKK0.31m
Brief: Orphazyme Says Anders Fink Vadsholt Will Step Down As CEO/CFO Of Company
Brief: Orphazyme Issues Major Shareholder Announcement
Brief: Orphazyme A/S Sees 2023 Operating Loss In Range Of Dkk 30 - 35 Mln
Brief: Orphazyme's Update Regarding Class Action Lawsuit In United States
Brief: Orphazyme Reports First Half Net Result Of DKK 63 Mln Versus Loss Of DKK 463.8 Mln
Brief: Orphazyme A/S Anticipates A Loss From Continuing Operations In Range Of DKK 40 Million - 45 Million
Brief: Orphazyme Announces Updated Notice To Holders Of ADSs Regarding Termination Of Deposit Agreement
Brief: Orphazyme Announces Publication Of 2021 Financial Results And Annual Report
Brief: Orphazyme Says Restructuring Proposal Adopted By Creditors
Brief: Orphazyme's Creditors Approve Company's Restructuring Proposal
Brief: Orphazyme Announces Changes To Their Board Of Directors
Brief: Orphazyme To Sell Assets And Business To Kempharm
Brief: Kempharm Announces Strategic Acquisition Of Arimoclomol From Orphazyme
Brief: Orphazyme Says Under In-Court-Restructuring To Sell Substantially All Of Its Assets And Business Activities To Kempharm, Inc.
Brief: Orphazyme Updates On In-Court Restructuring Proceedings
Brief: Orphazyme A/S Says Statutory Restructuring Plan Adopted By Creditors
Brief: Orphazyme: Statutory Restructuring Plan Adopted By Creditors
Brief: Orphazyme Announces Voluntary Delisting Of ADSs Has Become Effective
Brief: Orphazyme A/S - Danish Business Authority Approved To Extend Deadline For Filing Of Annual Report 2021